MD Anderson wants to 'be part of the game,' partners with Radiopharm Theranostics for radioligand joint venture
The University of Texas MD Anderson Cancer Center has linked arms with Australian biotech Radiopharm Theranostics to build a joint venture dubbed Radiopharm Ventures. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.